Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection Recalled by Lowlite Investments, Inc. D/B/A Olympia Pharmacy Due to Lack of Assurance of Sterility: FDA inspection findings...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Lowlite Investments, Inc. D/B/A Olympia Pharmacy directly.
Affected Products
Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Quantity: 1
Why Was This Recalled?
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Where Was This Sold?
This product was distributed nationwide across all 50 states.
About Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Lowlite Investments, Inc. D/B/A Olympia Pharmacy has 105 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report